Show simple item record

dc.contributor.authorNguta, JM
dc.contributor.authorAppiah-Opong, R
dc.contributor.authorNyarko, AK
dc.contributor.authorYeboah-Manu, D
dc.contributor.authorAddo, PG
dc.contributor.authorOtchere, ID
dc.contributor.authorKissi-Twum, A
dc.date.accessioned2017-05-12T11:28:05Z
dc.date.available2017-05-12T11:28:05Z
dc.date.issued2016
dc.identifier.citationInt J Mycobacteriol. 2016 Dec;5 Suppl 1:S106-S107en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/28043491
dc.identifier.urihttp://hdl.handle.net/11295/100892
dc.description.abstractTuberculosis (TB) caused by Mycobacterium tuberculosis remains a serious public health challenge towards which new hits are urgently needed. Medicinal plants remains a major source of new ligands against global infectious illnesses. In our laboratories, we are currently investigating locally used ethnobotanicals for novel compounds against zoonotic tuberculosis. The microplate alamar blue assay (MABA) was used to study the anti-TB activity while the CellTiter 96® AQueous Assay, which is composed of solutions of a novel tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS] and an electron coupling reagent (phenazine methosulfate) PMS, was used for cytotoxic studies. Correlation coefficients (R2) were used to compare the relationship between antimycobacterial activity of the eight crude extracts against nonpathogenic strains and the pathogenic Mycobacterium bovis. Minimum inhibitory concentration (MICs) values indicated that all the eight tested medicinal plant species had activity against all the three tested mycobacterial strains. Minimum inhibitory concentration value as low as 19.5µg/mL was observed against non-pathogenic strains M. bovis. Activity of the crude extracts against M. aurum was the best predictor of natural product activity against the pathogenic Mycobacterium bovis strain, with a correlation coefficient value (R2) of 0.1371. Results obtained from the current study validate, in part, the traditional utilization of the tested medicinal plants against tuberculosis. The unripe fruits from Solanum torvum are a potential source of safe and efficacious anti-TB crude drugs as well as a source for natural compounds that act as new anti-infection agents, and thus deserve further investigation towards development of a new class of molecules with activity against sensitive and drug resistant strains of M. bovis.en_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectAlamar blue (PubChem CID: 11077); Catalase (PubChem CID: 784); Crude extracts; EDTA (PubChem CID: 6049); Ethambutol (PubChem CID: 3279); Glycerol (PubChem CID: 753); Isoniazid (PubChem CID: 3767); L-glutamine (PubChem CID: 5961); MABA assay; MTS (PubChem CID: 4182497); MTS assay; Mycobacteria; Rifampicin (PubChem CID: 5381226); Selectivity index; Streptomycin (PubChem CID: 19649); Trypsin (PubChem CID: 23729580); Tuberculosisen_US
dc.titleIn vitro antimycobacterial activity and toxicity of eight medicinal plants against pathogenic and nonpathogenic mycobacterial strains.en_US
dc.typeArticleen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States